These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 568220)

  • 1. Induction of lysosomal storage by suramin.
    Buys CH; Bouma JM; Gruber M; Wisse E
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Sep; 304(2):183-90. PubMed ID: 568220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Decrease in the rats of intraliposomal proteolysis and labilization of rat liver lysosomes following suramin administration].
    Korolenko TA; Pupyshev AB; Malygin AE
    Biull Eksp Biol Med; 1980 Dec; 90(12):686-8. PubMed ID: 6781552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of Trypan Blue, suramin and aurothiomalate on the breakdown of 125 I-labelled albumin within rat liver lysosomes.
    Davies M; Lloyd JB; Beck F
    Biochem J; 1971 Jan; 121(1):21-6. PubMed ID: 5116540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of suramin on digestion of 14C-labelled albumin in heterolysosomes of rat liver subcellular fractions].
    Pupyshev AB; Malygin AE; Korolenko TA
    Biokhimiia; 1981 Jul; 46(7):1167-74. PubMed ID: 7272344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of intralysosomal protein catabolism using lysosomotropic agents--proteolysis and protease inhibitors].
    Korolenko TA; Pupyshev AB; Mudrakovskaia AV
    Vopr Med Khim; 1987; 33(5):93-6. PubMed ID: 3686902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Facilitation of the structural and functional disorders of liver lysosomes in toxic hepatitis due to the suppression of intralysosomal proteolysis].
    Korolenko TA; Pupyshev AB; Malygin AE; Gavrilova NI; Kurysheva NG
    Biull Eksp Biol Med; 1985 Aug; 100(8):169-72. PubMed ID: 3896340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of suramin and aurothiomalate on rat liver lysosomes.
    Davies M; Lloyd JB; Beck F
    Biochem J; 1969 Dec; 115(5):54P-55P. PubMed ID: 5360708
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of thiols, pH and cathepsin D in the lysosomal catabolism of serum albumin.
    Mego JL
    Biochem J; 1984 Mar; 218(3):775-83. PubMed ID: 6721834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the lysosomotropic drug suramin on islet lysosomal enzyme activities and the insulin-secretory response induced by various secretagogues.
    Panagiotidis G; Salehi AA; Lundquist I
    Pharmacology; 1991; 43(3):163-8. PubMed ID: 1723207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of formaldehyde-treated 131-I-albumin in the study of digestive vacuoles and some properties of these particles from mouse liver.
    Mego JL; Bertini F; McQueen JD
    J Cell Biol; 1967 Mar; 32(3):699-707. PubMed ID: 6034485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterophagic function and rate of intralysosomal proteolysis during lysosomotropic agents administration.
    Korolenko TA; Pupyshev AB; Malygin AE
    Acta Biol Med Ger; 1981; 40(10-11):1613-7. PubMed ID: 7342605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteolysis of formaldehyde-treated albumin in Kupffer cells and its inhibition by suramin.
    Buys CH; Elferink MG; Bouma JM; Gruber M; Nieuwenhuis P
    J Reticuloendothel Soc; 1973 Aug; 14(2):209-23. PubMed ID: 4733127
    [No Abstract]   [Full Text] [Related]  

  • 13. The release of intralysosomally-stored 125I-Triton WR-1339 and lysosomal enzymes from the isolated perfused rat liver in the presence and absence of cytochalasin B.
    Michelakakis H; Danpure CJ
    Biochem Pharmacol; 1986 Mar; 35(6):933-8. PubMed ID: 3082335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Labilising effect of suramin on rat kidney lysosomes in vivo.
    Akanji MA
    Toxicol Lett; 1984 Dec; 23(3):273-7. PubMed ID: 6523521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rat kidney lysosomal membrane damage induced by suramin in vitro and in vivo.
    Akanji MA
    Pharmacol Toxicol; 1988 May; 62(5):318-21. PubMed ID: 3413035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung macrophage defense responses during suramin-induced lysosomal dysfunction.
    Warr GA; Jakab GJ
    Exp Mol Pathol; 1983 Apr; 38(2):193-207. PubMed ID: 6832343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitions of cathepsin B and cathepsin L by E-64 in vivo. II. Incorporation of [3H]E-64 into rat liver lysosomes in vivo.
    Hashida S; Kominami E; Katunuma N
    J Biochem; 1982 Apr; 91(4):1373-80. PubMed ID: 7096292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of d-tubocurarine in rat liver lysosomes. Lysosomal uptake, biliary excretion and displacement by quinacrine in vivo.
    Weitering JG; Lammers W; Meijer DK; Mulder GJ
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Oct; 299(3):277-81. PubMed ID: 927554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of suramin, a polyanionic drug inducing lysosomal storage disorders on tooth germs in vitro.
    Gritli-Linde A; Ruch JV; Mark MP; Lécolle S; Goldberg M
    Biol Cell; 1994; 81(2):143-52. PubMed ID: 7849606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A suramin derivative induces enterocyte-like differentiation of human colon cancer cells without lysosomal storage disorder.
    Baghdiguian S; Nickel P; Marvaldi J; Fantini J
    Anticancer Drugs; 1990 Oct; 1(1):59-66. PubMed ID: 2131040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.